116 related articles for article (PubMed ID: 27402272)
1. Effect of glucocorticoid withdrawal on glucocorticoid inducing bone impairment.
Shen G; Ren H; Qiu T; Liang D; Wei Q; Tang J; Zhang Z; Yao Z; Zhao W; Jiang X
Biochem Biophys Res Commun; 2016 Sep; 477(4):1059-1064. PubMed ID: 27402272
[TBL] [Abstract][Full Text] [Related]
2. Effects of combined ovariectomy with dexamethasone on rat lumbar vertebrae.
Ren H; Liang D; Shen G; Yao Z; Jiang X; Tang J; Cui J; Lin S
Menopause; 2016 Apr; 23(4):441-50. PubMed ID: 26694734
[TBL] [Abstract][Full Text] [Related]
3. Variance of spinal osteoporosis induced by dexamethasone and methylprednisolone and its associated mechanism.
Ren H; Liang D; Jiang X; Tang J; Cui J; Wei Q; Zhang S; Yao Z; Shen G; Lin S
Steroids; 2015 Oct; 102():65-75. PubMed ID: 26216207
[TBL] [Abstract][Full Text] [Related]
4. [PHASIC CHANGES OF BONE MASS, BONE TURNOVER MARKERS, AND ESTROGEN LEVELS AT DIFFERENT TIME POINTS AFTER GLUCOCORTICOID INTERVENTION AND THEIR CORRELATION IN RATS].
Ren H; Shen G; Jiang X; Liang D; Tang J; Cui J; Lin S; Zhuang H; Yang Z; Zhang S; Yao Z
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2015 Mar; 29(3):307-14. PubMed ID: 26455196
[TBL] [Abstract][Full Text] [Related]
5. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
Khan MP; Mishra JS; Sharan K; Yadav M; Singh AK; Srivastava A; Kumar S; Bhaduaria S; Maurya R; Sanyal S; Chattopadhyay N
Phytomedicine; 2013 Nov; 20(14):1256-66. PubMed ID: 23928508
[TBL] [Abstract][Full Text] [Related]
6. [Dynamic effects of glucocorticoid on bone mineral density and microarchitecture: experiment with rats].
Liu SP; Chen J; Yang SM; Wu XP; Liao EY; Sheng ZF; Mo H; Ma YL; Zhang YH; Liu W; Jin Y; Dai RC
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2281-4. PubMed ID: 19087680
[TBL] [Abstract][Full Text] [Related]
7. Preventive effects of berberine on glucocorticoid-induced osteoporosis in rats.
Xu D; Yang W; Zhou C; Liu Y; Xu B
Planta Med; 2010 Nov; 76(16):1809-13. PubMed ID: 20577944
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of withdrawal of bisphosphonate incadronate disodium (YM175) on bone mineral density, mass, structure, and turnover in the lumbar vertebrae of ovariectomized rats.
Tamura Y; Miyakoshi N; Itoi E; Abe T; Kudo T; Tsuchida T; Kasukawa Y; Sato K
J Bone Miner Res; 2001 Mar; 16(3):541-9. PubMed ID: 11277272
[TBL] [Abstract][Full Text] [Related]
9. Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength.
Yao W; Dai W; Jiang L; Lay EY; Zhong Z; Ritchie RO; Li X; Ke H; Lane NE
Osteoporos Int; 2016 Jan; 27(1):283-294. PubMed ID: 26384674
[TBL] [Abstract][Full Text] [Related]
10. Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis.
Dalle Carbonare L; Arlot ME; Chavassieux PM; Roux JP; Portero NR; Meunier PJ
J Bone Miner Res; 2001 Jan; 16(1):97-103. PubMed ID: 11149495
[TBL] [Abstract][Full Text] [Related]
11. Loss of vertebral bone and mechanical strength in estrogen-deficient rats is prevented by long-term administration of zoledronic acid.
Glatt M; Pataki A; Evans GP; Hornby SB; Green JR
Osteoporos Int; 2004 Sep; 15(9):707-15. PubMed ID: 15024556
[TBL] [Abstract][Full Text] [Related]
12. Influence of glucocorticoid on bone in 3-, 6-, and 12-month-old rats as determined by bone mass and histomorphometry.
Ogoshi T; Hagino H; Fukata S; Tanishima S; Okano T; Teshima R
Mod Rheumatol; 2008; 18(6):552-61. PubMed ID: 18648735
[TBL] [Abstract][Full Text] [Related]
13. Short-term glucocorticoid treatment causes spinal osteoporosis in ovariectomized rats.
Böcker W; El Khassawna T; Bauer N; Brodsky K; Weisweiler D; Govindarajan P; Schlewitz G; Kampschulte M; Dürselen L; Thormann U; Szalay G; Schnettler R; Langheinrich AC; Heiss C
Eur Spine J; 2014 Nov; 23(11):2437-48. PubMed ID: 25077942
[TBL] [Abstract][Full Text] [Related]
14. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
Boutsen Y; Jamart J; Esselinckx W; Devogelaer JP
J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473
[TBL] [Abstract][Full Text] [Related]
15. Clodronate prevents osteopenia and loss of trabecular connectivity in estrogen-deficient rats.
Kippo K; Hannuniemi R; Isaksson P; Laurén L; Osterman T; Peng Z; Tuukkanen J; Kuurtamo P; Väänänen HK; Sellman R
J Bone Miner Res; 1998 Feb; 13(2):287-96. PubMed ID: 9495523
[TBL] [Abstract][Full Text] [Related]
16. Effects of the combined Herba Epimedii and Fructus Ligustri Lucidi on bone turnover and TGF-β1/Smads pathway in GIOP rats.
Yang Y; Nian H; Tang X; Wang X; Liu R
J Ethnopharmacol; 2017 Apr; 201():91-99. PubMed ID: 28254481
[TBL] [Abstract][Full Text] [Related]
17. Spinal cord injury causes more damage to bone mass, bone structure, biomechanical properties and bone metabolism than sciatic neurectomy in young rats.
Jiang SD; Jiang LS; Dai LY
Osteoporos Int; 2006 Oct; 17(10):1552-61. PubMed ID: 16874443
[TBL] [Abstract][Full Text] [Related]
18. Ibandronate for prevention and treatment of glucocorticoid-induced osteoporosis in rabbits.
Zhang KJ; Zhang J; Kang ZK; Xue XM; Kang JF; Li YW; Dong HN; Liu DG
Rheumatol Int; 2012 Nov; 32(11):3405-11. PubMed ID: 22057134
[TBL] [Abstract][Full Text] [Related]
19. Skeletal site-specific effects of endurance running on structure and strength of tibia, lumbar vertebrae, and mandible in male Sprague-Dawley rats.
Bott KN; Sacco SM; Turnbull PC; Longo AB; Ward WE; Peters SJ
Appl Physiol Nutr Metab; 2016 Jun; 41(6):597-604. PubMed ID: 27191195
[TBL] [Abstract][Full Text] [Related]
20. Yeast-incorporated gallium attenuates glucocorticoid-induced bone loss in rats by inhibition of bone resorption.
Ren Z; Yang L; Xue F; Meng Q; Wang K; Wu X; Ji C; Jiang T; Liu D; Zhou L; Zhang J; Fu Q
Biol Trace Elem Res; 2013 Jun; 152(3):396-402. PubMed ID: 23532566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]